Clinical Associations of Thyroid Hormone Levels with the Risk of Atherosclerosis in Euthyroid Type 2 Diabetic Patients in Central China
Table 3
Prevalence ratio of atherosclerosis based on Cox regression on each tertile of thyroid hormone levels.
Variable
Model 1
Model 2
PR
CI
value
PR
CI
value
FT3
Q1
Q1 < 4.21
1.00
Ref
1.00
Ref
Q2
4.21 ≤ Q2 < 4.63
0.71
0.55 to 0.92
0.009
0.74
0.56 to 0.97
0.029
Q3
Q3 ≤ 4.63
0.52
0.39 to 0.70
<0.001
0.63
0.46 to 0.87
0.005
FT4
Q1
Q1 < 15.2
1.00
Ref
1.00
Ref
Q2
15.2 ≤ Q2 < 17.2
0.89
0.68 to 1.20
0.389
0.97
0.74 to 1.30
0.851
Q3
Q3 ≤ 17.2
0.72
0.55 to 0.95
0.021
0.82
0.62 to 1.10
0.195
TSH
Q1
Q1 < 1.63
1.00
Ref
1.00
Ref
Q2
1.63 ≤ Q2 < 2.69
1.20
0.91 to 1.60
0.193
1.20
0.91 to 1.70
0.174
Q3
Q3 ≤ 2.69
1.20
0.90 to 1.60
0.229
1.20
0.88 to 1.60
0.256
FT3/FT4
Q1
Q1 < 0.26
1.00
Ref
1.00
Ref
Q2
0.26 ≤ Q2 < 0.29
1.10
0.85 to 1.50
0.458
1.10
0.84 to 1.50
0.434
Q3
Q3 ≤ 0.29
1.00
0.78 to 1.40
0.834
1.00
0.77 to 1.40
0.794
Model 1: adjusted for age and BMI. Model 2: adjusted for age, BMI, duration of T2D, smoking status, SBP, TC, family history of T2D, and medications on hyperlipidemia. PR: prevalence ratio. CI: 95% confidence interval of PR.
